Skip to main content
. 2021 Apr 12;18(2):686–708. doi: 10.1007/s13311-021-01027-4

Fig. 3.

Fig. 3

(a) Mapping of [18F]flutemetemol amyloid PET SUVR values (x-axis) into Centiloids (y-axis) [158]. (b) Side-by-Side comparison of [18F]florbetapir SUVR values and AβL values across Alzheimer’s disease stages from the ADNI database [160]. Note that AβL values have well-defined floor and ceiling levels. (c) Side-by-Side comparison of longitudinal change in global TauL and regional SUVR values from [18F]flortaucipir scans in the ADNI database (a was originally published in the European Journal of Nuclear Medicine and Molecular Imaging [158], reproduced under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/); b was originally published in the Journal of Nuclear Medicine [160] © SNMMI; c was originally published in the Journal of Nuclear Medicine [162] © SNMMI; axis labels have been redrawn for legibility)

HHS Vulnerability Disclosure